title: Stable knock-down of the sphingosine 1-phosphate receptor S1P1 influences multiple functions of human endothelial cells.
abstract: OBJECTIVE
  Sphingosine 1-phosphate (S1P) is a bioactive phospholipid acting both as a ligand for the G protein-coupled receptors S1P1-5 and as a second messenger. Because S1P1 knockout is lethal in the transgenic mouse, an alternative approach to study the function of S1P1 in endothelial cells is needed.
  
  
  RESULTS
  All human endothelial cells analyzed expressed abundant S1P1 transcripts. We permanently silenced (by RNA interference) the expression of S1P1 in the human endothelial cell lines AS-M.5 and ISO-HAS.1. The S1P1 knock-down cells manifested a distinct morphology and showed neither actin ruffles in response to S1P nor an angiogenic reaction. In addition, these cells were more sensitive to oxidant stress-mediated injury. New S1P1-dependent gene targets were identified in human endothelial cells. S1P1 silencing decreased the expression of platelet-endothelial cell adhesion molecule-1 and VE-cadherin and abolished the induction of E-selectin after cell stimulation with lipopolysaccharide or tumor necrosis factor-alpha. Microarray analysis revealed downregulation of further endothelial specific transcripts after S1P1 silencing.
  
  
  CONCLUSIONS
  Long-term silencing of S1P1 enabled us for the first time to demonstrate the involvement of S1P1 in key functions of endothelial cells and to identify new S1P1-dependent gene targets.
authors.affiliation: Institute for Prevention of Cardiovascular Diseases, Ludwig Maximilian University, Munich, Germany. vera.krump-konvalinkova@klp.med.uni-muenchen.de
authors.forename: Vera
authors.initials: V
authors.lastname: Krump-Konvalinkova
authors.forename: Satoshi
authors.initials: S
authors.lastname: Yasuda
authors.forename: Tina
authors.initials: T
authors.lastname: Rubic
authors.forename: Natalia
authors.initials: N
authors.lastname: Makarova
authors.forename: Jörg
authors.initials: J
authors.lastname: Mages
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Erl
authors.forename: Claudia
authors.initials: C
authors.lastname: Vosseler
authors.forename: C James
authors.initials: CJ
authors.lastname: Kirkpatrick
authors.forename: Gabor
authors.initials: G
authors.lastname: Tigyi
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Siess
mesh_terms: D015703:Antigens, CD; D015820:Cadherins / Q000235:genetics; D002460:Cell Line; D004730:Endothelium, Vascular / Q000166:cytology / Q000502:physiology*; D020868:Gene Silencing; D006394:Hemangiosarcoma; D006801:Humans; D008833:Microcirculation; D008967:Molecular Biology / Q000379:methods*; D018919:Neovascularization, Physiologic / Q000502:physiology; D020411:Oligonucleotide Array Sequence Analysis; D018384:Oxidative Stress / Q000502:physiology; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000235:genetics; D011652:Pulmonary Circulation; D012333:RNA, Messenger / Q000235:genetics; D034741:RNA, Small Interfering / Q000235:genetics*; D049349:Receptors, Lysosphingolipid / Q000235:genetics* / Q000378:metabolism*; D015290:Second Messenger Systems / Q000502:physiology; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D014471:Umbilical Veins / Q000166:cytology; D019043:Vascular Neoplasms; D014657:Vasculitis / Q000235:genetics / Q000276:immunology / Q000503:physiopathology; D000099152:Cadherin 5
chemical_list: D015703:Antigens, CD; D015820:Cadherins; D019408:Platelet Endothelial Cell Adhesion Molecule-1; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D049349:Receptors, Lysosphingolipid; D014409:Tumor Necrosis Factor-alpha; D000099152:Cadherin 5